Fuller & Thaler Asset Management
LMAT icon

Fuller & Thaler Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Fuller & Thaler Asset Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-49,960
Closed -$2.02M – 551
2020
Q4 		$2.02M Sell
49,960
-2,630
-5% -$94K 0.02% 326
2020
Q3 		$1.71M Buy
+52,590
New +$1.58M 0.02% 307

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
SCA
Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Fuller & Thaler Asset Management's LMAT Position: Q1 2021 in Review

Fuller & Thaler Asset Management sold out of LeMaitre Vascular (LMAT) in Q1 2021, closing a stake of 49,960 shares — an estimated $2.02M sold.

Fuller & Thaler Asset Management first reported a position in LMAT in Q3 2020 and held it in 2 quarters. The position peaked at $2.02M in Q4 2020. 179 funds tracked by Wall St. Rank hold LMAT as of Q1 2021.

  • Fuller & Thaler Asset Management reported no remaining LeMaitre Vascular position as of Q1 2021 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 49,960 LeMaitre Vascular shares in Q1 2021, an estimated $2.02M.
  • Fuller & Thaler Asset Management first reported a position in LeMaitre Vascular in Q3 2020 and held it in 2 quarters.
  • Fuller & Thaler Asset Management's LeMaitre Vascular position peaked at $2.02M in Q4 2020.
  • 179 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2021.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2021, filed 13 May 2021.